GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » 3-Year Sharpe Ratio

Getinge AB (OSTO:GETI B) 3-Year Sharpe Ratio : -0.28 (As of Jul. 05, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-05), Getinge AB's 3-Year Sharpe Ratio is -0.28.


Competitive Comparison of Getinge AB's 3-Year Sharpe Ratio

For the Medical Devices subindustry, Getinge AB's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's 3-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's 3-Year Sharpe Ratio falls into.


;
;

Getinge AB 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


Getinge AB  (OSTO:GETI B) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Getinge AB 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Getinge AB's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Traded in Other Exchanges
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

No Headlines